Cancer genes with translocations.

his table is a list of the cancer genes that are characterised by translocations. The full version of this table can be downloaded here .This is part of Table 1 in Futreal et al.

Symbol	Name	Entrez GeneID	Tumour Types (Somatic Mutations)	Tumour Types (Germline Mutations)	Cancer Syndrome	Translocation Partner	Synonyms
ABL1	v-abl Abelson murine leukemia viral oncogene homolog 1	25	CML, ALL, T-ALL			BCR, ETV6, NUP214	25, ABL, ABL1, ENSG00000097007, JTK7, P00519, bcr/abl, c-ABL, p150, v-abl
ABL2	v-abl Abelson murine leukemia viral oncogene homolog 2	27	AML			ETV6	27, ABL2, ABLL, ARG, ENSG00000143322, P42684, RP11-177A2_3
ACSL3	acyl-CoA synthetase long-chain family member 3	2181	prostate			ETV1	2181, ACS3, ACSL3, ASPM, CCDS2455.1, ENSG00000123983, FACL3, O95573, PRO2194, Q6PIM8
AF15Q14	AF15q14 protein	57082	AML			MLL	57082, AF15Q14, CASC5, D40, ENSG00000137812, Q8NG31
AF1Q	ALL1-fused gene from chromosome 1q	10962	ALL			MLL	10962, AF1Q, CCDS982.1, ENSG00000213190, MLLT11, Q13015, Q6FGF7
AF3p21	SH3 protein interacting with Nck, 90 kDa (ALL1 fused gene from 3p21)	51517	ALL			MLL	51517, AF3P21, AF3p21, CCDS2776.1, ENSG00000213672, NCKIPSD, ORF1, Q6GU34, Q8TC10, Q9NZQ3, SPIN90, WASLBP, WISH
AF5q31	ALL1 fused gene from 5q31	27125	ALL			MLL	27125, AF5Q31, AF5q31, AFF4, CCDS4164.1, ENSG00000072364, MCEF, Q9UHB7
AKAP9	A kinase (PRKA) anchor protein (yotiao) 9	10142	papillary thyroid			BRAF	10142, AKAP350, AKAP450, AKAP9, AKAP9_ENST00000356239, AKAP9_NM_005751, B3KQF9, CCDS5622, CG-NAP, ENSG00000127914, HYPERION, KIAA0803, MU-RMS-40_16A, PRKA9, Q5GIA7, Q8IW64, Q99996, YOTIAO
ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	217	leiomyoma			HMGA2	217, ALDH-E2, ALDH2, ALDHI, ALDM, CCDS9155.1, ENSG00000111275, MGC1806, P05091, Q53FB6, Q9UN17
ALK	anaplastic lymphoma kinase (Ki-1)	238	ALCL, NSCLC, Neuroblastoma	neuroblastoma	Familial neuroblastoma	NPM1, TPM3, TFG, TPM4, ATIC, CLTC, MSN, ALO17, CARS, EML4, KIF5B, C2orf22	238, ALK, CD246, ENSG00000171094, Q9UM73, TFG/ALK
ALO17	KIAA1618 protein	57714	ALCL			ALK	57674, ALO17, C17orf27, CCDS32761.1, ENSG00000173821, KIAA1554, Q63HN8, Q6ZSK6, RNF213
ARHGEF12	RHO guanine nucleotide exchange factor (GEF) 12 (LARG)	23365	AML			MLL	23365, ARHGEF12, DKFZp686O2372, ENSG00000196914, KIAA0382, LARG, PRO2792, Q6P526, Q9NZN5
ARHH	RAS homolog gene family, member H (TTF)	399	NHL			BCL6	399, ARHH, CCDS3458.1, ENSG00000168421, RHOH, RhoH, TTF
ARNT	aryl hydrocarbon receptor nuclear translocator	405	AML			ETV6	405, ARNT, CCDS970.1, ENSG00000143437, HIF-1beta, HIF1B, HIF1BETA, O43392, P27540, Q53F30, Q59ED4, Q5QP39, Q6P9C1, TANGO
ASPSCR1	alveolar soft part sarcoma chromosome region, candidate 1	79058	alveolar soft part sarcoma			TFE3	79058, ASPSCR1, CCDS11796.1, ENSG00000169696, Q9BZE9
ATF1	activating transcription factor 1	466	malignant melanoma of soft parts , angiomatoid fibrous histiocytoma			EWSR1, FUS	466, ATF1, CCDS8803.1, ENSG00000123268, P18846, TREB36
ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	471	ALCL			ALK	471, AICARFT, ATIC, CCDS2398.1, ENSG00000138363, IMPCHASE, P31939, PURH, Q53S28
BCL10	B-cell CLL/lymphoma 10	8915	MALT			IGH@	8915, BCL10, CARMEN, CCDS704.1, CIPER, CLAP, ENSG00000142867, c-E10, mE10
BCL11A	B-cell CLL/lymphoma 11A	53335	B-CLL			IGH@	53335, BCL11A, BCL11A-L, BCL11A-S, BCL11A-XL, CCDS1862.1, CTIP1, ENSG00000119866, EVI9, FLJ10173, FLJ34997, KIAA1809, Q53TE8, Q53TS1, Q9H165
BCL11B	B-cell CLL/lymphoma 11B (CTIP2)	64919	T-ALL			TLX3	64919, BCL11B, CCDS9950.1, CTIP-2, CTIP2, ENSG00000127152, Q9C0K0, RIT1, hRIT1-alpha
BCL2	B-cell CLL/lymphoma 2	596	NHL, CLL			IGH@	596, BCL2, Bcl-2, CCDS11981.1, ENSG00000171791
BCL3	B-cell CLL/lymphoma 3	602	CLL			IGH@	602, BCL3, BCL4, CCDS12642.1, D19S37, ENSG00000069399, P20749
BCL5	B-cell CLL/lymphoma 5	603	CLL			MYC
BCL6	B-cell CLL/lymphoma 6	604	NHL, CLL			IG loci, ZNFN1A1, LCP1, PIM1, TFRC, CIITA, NACA, HSPCB, HSPCA, HIST1H4I, IL21R, POU2AF1, ARHH, EIF4A2, SFRS3	604, BCL5, BCL6, BCL6A, CCDS3289.1, ENSG00000113916, LAZ3, P41182, ZBTB27, ZNF51
BCL7A	B-cell CLL/lymphoma 7A	605	BNHL			MYC	605, BCL7, BCL7A, ENSG00000110987
BCL9	B-cell CLL/lymphoma 9	607	B-ALL			IGH@, IGL@	607, BCL9, ENSG00000116128, LGS, MGC131591
BCOR	BCL6 corepressor	54880	retinoblastoma, AML, APL(translocation)			RARA	54880, ANOP2, BCOR, CCDS14250.1, ENSG00000183337, FLJ20285, FLJ38041, KIAA1575, MAA2, MCOPS2, MGC131961, MGC71031
BCR	breakpoint cluster region	613	CML, ALL, AML			ABL1, FGFR1, JAK2	613, ALL, BCR, BCR1, CCDS13806.1, CML, D22S11, D22S662, ENSG00000186716, FLJ16453, P11274, PHL
BIRC3	baculoviral IAP repeat-containing 3	330	MALT			MALT1	330, AIP1, API2, BIRC3, CCDS8315.1, CIAP2, ENSG00000023445, HAIP1, HIAP1, MALT2, MIHC, Q13489, RNF49, cIAP2, hiap-1
BRAF	v-raf murine sarcoma viral oncogene homolog B1	673	melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma			AKAP9, KIAA1549	673, B-raf 1, B-raf1, BRAF, BRAF1, CCDS5863.1, ENSG00000157764, MGC126806, MGC138284, P15056, RAFB1
BRD3	bromodomain containing 3	8019	lethal midline carcinoma of young people			C15orf55	8019, BRD3, ENSG00000169925, KIAA0043, ORFX, Q15059, RING3L
BRD4	bromodomain containing 4	23476	lethal midline carcinoma of young people			C15orf55	23476, BRD4, BRD4_ENST00000263377, CAP, CCDS12328, ENSG00000141867, HUNK1, HUNKI, MCAP, O60885, Q05BM2, Q5BJ26, Q6NXE4, Q6PIS5, Q96HN0
BTG1	B-cell translocation gene 1, anti-proliferative	694	BCLL			MYC	694, BTG1, CCDS9043.1, ENSG00000133639, P62324, Q6IBC8
C12orf9	chromosome 12 open reading frame 9	93669	lipoma			LPP
C15orf21	chromosome 15 open reading frame 21	283651	prostate			ETV1
C15orf55	chromosome 15 open reading frame 55	256646	lethal midline carcinoma			BRD3, BRD4	256646, C15orf55, CCDS32190.1, ENSG00000184507, NUT, Q86Y26, Q86YS8, Q9NTB3
C16orf75	chromosome 16 open reading frame 75	116028	PMBL, Hodgkin Lymphona,			CIITA	116028, C16orf75, CCDS10548.1, ENSG00000175643, MGC24665, Q96E14, RMI2
C2orf44	chromosome 2 open reading frame 44	80304	NSCLC			ALK	80304, C2orf44, CCDS1705.1, ENSG00000163026, FLJ21945, PP384, Q8IYK0, Q9H6R7, Q9HBP5
CAMTA1	calmodulin binding transcription activator 1	611501	epitheliod hemangioendothelioma			WWTR1	23261, CAMTA1, CCDS30576.1, ENSG00000171735, KIAA0833, Q7Z7P1, Q96S92, Q9Y6Y1
CANT1	calcium activated nucleotidase 1	124583	prostate			ETV4	124583, CANT1, CCDS11760.1, ENSG00000171302, Q8WVQ1, SCAN-1, SHAPY
CARS	cysteinyl-tRNA synthetase	833	ALCL			ALK	833, CARS, CCDS7742.1, ENSG00000110619, P49589, Q53HG6
CBFA2T1	core-binding factor, runt domain, alpha subunit 2;translocated to, 1 (ETO)	862	AML			MLL, RUNX1	862, CBFA2T1, CCDS6257.1, ENSG00000079102, Q7Z4J5, Q9HBV9, RUNX1T1
CBFA2T3	core-binding factor, runt domain, alpha subunit 2; translocated to, 3 (MTG-16)	863	AML			RUNX1	863, CBFA2T3, CCDS10972.1, ENSG00000129993, ETO2, MTG16, MTGR2, O60615, O60616, O60617, O75081, Q0P5Z6, ZMYND4
CBFB	core-binding factor, beta subunit	865	AML			MYH11	865, CBFB, CCDS10827.1, ENSG00000067955, PEBP2B, Q13951, Q9HCT2
CBL	Cas-Br-M (murine) ecotropic retroviral transforming	867	AML, JMML, MDS			MLL	867, C-CBL, CBL, CBL2, CCDS8418.1, ENSG00000110395, RNF55
CCDC6	coiled-coil domain containing 6	8030	NSCLC			RET	8030, CCDC6, CCDS7257.1, D10S170, ENSG00000108091, H4, PTC, Q05CP8, Q16204, Q6GSG7, TPC, TST1
CCNB1IP1	cyclin B1 interacting protein 1, E3 ubiquitin protein ligase	57820	leiomyoma			HMGA2	57820, C14orf18, CCDS9547.1, CCNB1IP1, ENSG00000100814, HEI10, Q9NPC3
CCND1	cyclin D1	595	CLL, B-ALL, breast			IGH@, FSTL3	595, BCL1, CCDS8191.1, CCND1, D11S287E, ENSG00000110092, PRAD1, U21B31
CCND2	cyclin D2	894	NHL,CLL			IGL@	894, CCDS8524.1, CCND2, ENSG00000118971, KIAK0002, MGC102758, P30279, Q53ER2
CCND3	cyclin D3	896	MM			IGH@	896, CCDS4863.1, CCND3, ENSG00000112576, P30281, Q6FG62
CD273	programmed cell death 1 ligand 2	80380	PMBL, Hodgkin Lymphona,			CIITA	80380, B7DC, Btdc, CCDS6465.1, CD273, ENSG00000197646, MGC142238, MGC142240, PD-L2, PDCD1L2, PDCD1LG2, PDL2, Q2LC89, Q9BQ51, bA574F11_2
CD274	CD274 molecule	29126	PMBL, Hodgkin Lymphona,			CIITA	29126, B7-H, B7H1, CCDS6464.1, CD274, ENSG00000120217, MGC142294, MGC142296, PD-L1, PDCD1L1, PDCD1LG1, PDL1, Q0GN75, Q9NZQ7
CD74	CD74 molecule, major histocompatibility complex, class II invariant chain	972	NSCLC			ROS1	972, CCDS34276.1, CD74, DHLAG, ENSG00000019582, HLADG, Ia-GAMMA, O19685, Q8SNA0, Q9TNQ4, Q9TNQ6, protein 41
CDH11	cadherin 11, type 2, OB-cadherin (osteoblast)	1009	aneurysmal bone cysts			USP6	1009, CAD11, CCDS10803.1, CDH11, ENSG00000140937, OB, P55287, Q59EQ1, Q96CZ9
CDK6	cyclin-dependent kinase 6	1021	ALL			MLLT10	1021, CCDS5628.1, CDK6, ENSG00000105810, MGC59692, PLSTIRE, Q00534
CDX2	caudal type homeo box transcription factor 2	1045	AML			ETV6	1045, CCDS9328.1, CDX2, CDX3, ENSG00000165556, Q5VTU7, Q99626, Q9UD92
CEP1	centrosomal protein 1	11064	MPD, NHL			FGFR1	11064, A2A2Y1, CCDS35118.1, CEP1, CEP110, CNTRL, ENSG00000119397, Q3MN79, Q5FWF8, Q5JVD0, Q5JVD1, Q5JVD6, Q6PKC1, Q7Z7A1, Q8TEP3, Q9Y489
CHCHD7	coiled-coil-helix-coiled-coil-helix domain containing 7	79145	salivary adenoma			PLAG1	79145, CCDS34896.1, CHCHD7, ENSG00000170791, FLJ40966, MGC2217, Q9BUK0
CHIC2	cysteine-rich hydrophobic domain 2	26511	AML			ETV6	26511, BTL, CCDS3493.1, CHIC2, Q9UKJ5
CHN1	chimerin (chimaerin) 1	1123	extraskeletal myxoid chondrosarcoma			TAF15	1123, ARHGAP2, CHN, CHN1, ENSG00000128656, RHOGAP2, RhoGAP2, n-chimerin
CIITA	class II, major histocompatibility complex, transactivator	4261	PMBL, Hodgkin Lymphona,			FLJ27352, CD274, CD273, RALGDS, RUNDC2A, C16orf75, BCL6	4261, A0N0N9, C2TA, CCDS10544.1, CIITA, ENSG00000179583, MHC2TA, P33076, Q29704, Q66X48, Q8SNB7, Q96KL4
CLTC	clathrin, heavy polypeptide (Hc)	1213	ALCL, renal			ALK, TFE3	1213, CCDS32696.1, CLTC, CLTCL2, ENSG00000141367, Q00610, Q49AL0
CLTCL1	clathrin, heavy polypeptide-like 1	8218	ALCL			?	8218, CLTCL, CLTCL1, ENSG00000070371, P53675
CMKOR1	chemokine orphan receptor 1	57007	lipoma			HMGA2	57007, CCDS2516.1, CMKOR1, CXCR7, ENSG00000144476, GPR159, P25106, RDC1
COL1A1	collagen, type I, alpha 1	1277	dermatofibrosarcoma protuberans, aneurysmal bone cyst			PDGFB, USP6	1277, CCDS11561.1, COL1A1, ENSG00000108821, OI4, P02452, Q6LAN8, Q9UMA6
COX6C	cytochrome c oxidase subunit VIc	1345	uterine leiomyoma			HMGA2	1345, CCDS6284.1, COX6C, ENSG00000164919, P09669
CREB1	cAMP responsive element binding protein 1	1385	clear cell sarcoma, angiomatoid fibrous histiocytoma			EWSR1	1385, CREB1, ENSG00000118260
CREB3L1	cAMP responsive element binding protein 3-like 1	90993	myxofibrosarcoma			FUS	90993, B2RA75, CREB3L1, ENSG00000157613, OASIS, Q96BA8
CREB3L2	cAMP responsive element binding protein 3-like 2	64764	fibromyxoid sarcoma			FUS	64764, A2RRN1, BBF2H7, CCDS34760.1, CREB3L2, ENSG00000182158, MGC131709, MGC71006, Q6ZMR6, Q70SY1, Q8IY69, TCAG_1951439
CREBBP	CREB binding protein (CBP)	1387	ALL, AML, DLBCL, B-NHL			MLL, MORF, RUNXBP2	1387, CBP, CCDS10509.1, CREBBP, ENSG00000005339, RSTS, RTS
CRLF2	cytokine receptor-like factor 2	64109	B-ALL, Downs associated ALL			P2RY8, IGH@	CRLF2, ENSG00000205755, Q4V300
CRTC3	CREB regulated transcription coactivator 3	64784	salivary gland mucoepidermoid			MAML2	64784, CCDS32331.1, CRTC3, ENSG00000140577, FLJ21868, Q6DK61, Q6DK62, Q6UUV7, Q8TEF4, Q9H6U2, TORC3
CTNNB1	catenin (cadherin-associated protein), beta 1	1499	colorectal, cvarian, hepatoblastoma, others, pleomorphic salivary adenoma			PLAG1	1499, CCDS2694.1, CTNNB, CTNNB1, ENSG00000168036, P35222
D10S170	DNA segment on chromosome 10 (unique) 170, H4 gene (PTC1)	8030	papillary thyroid, CML			RET, PDGFRB
DDIT3	DNA-damage-inducible transcript 3	1649	liposarcoma			FUS	1649, CCDS8943.1, CEBPZ, CHOP, CHOP10, DDIT3, ENSG00000175197, GADD153, MGC4154, P35638, Q53YD1, _C/EBP zeta_
DDX10	DEAD (Asp-Glu-Ala-Asp) box polypeptide 10	1662	AML*			NUP98	1662, CCDS8342.1, DDX10, ENSG00000178105, HRH-J8, Q13206, Q59EC7, Q86VR6
DDX5	DEAD (Asp-Glu-Ala-Asp) box polypeptide 5	1655	prostate			ETV4	1655, CCDS11659.1, DDX5, DKFZp686J01190, ENSG00000108654, G17P1, HLR1, HUMP68, P17844, Q7Z2V5, p68
DDX6	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6	1656	B-NHL			IGH@	1656, DDX6, ENSG00000110367, FLJ36338, HLR2, P26196, P54, Q8IV96, RCK
DEK	DEK oncogene (DNA binding)	7913	AML			NUP214	7913, CCDS34344.1, D6S231E, DEK, ENSG00000124795, P35659
DUX4	double homeobox, 4	22947	soft tissue sarcoma			CIC	CCDS54828, DUX4, E0YLM6, F5GZ66, F8QWU0, F8QWU1, F8QWU2, P0CJ85, P0CJ86, P0CJ88, P0CJ89, P0CJ90, Q13060, Q14546, Q14547
EBF1	early B-cell factor 1	1879	lipoma			HMGA2	1879, CCDS4343.1, COE1, EBF, EBF1, ENSG00000164330, O/E-1, OLF1, Q9UH73
EIF4A2	eukaryotic translation initiation factor 4A, isoform 2	1974	NHL			BCL6	1974, BM-010, CCDS3282.1, DDX2B, EIF4A, EIF4A2, EIF4F, ENSG00000156976
ELF4	E74-like factor 4 (ets domain transcription factor)	2000	AML			ERG	2000, CCDS14617.1, ELF4, ELFR, ENSG00000102034, MEF, Q5H9H5, Q99607, RP3-510O21_2
ELK4	ELK4, ETS-domain protein (SRF accessory protein 1)	2005	prostate			SLC45A3	2005, CCDS1456.1, ELK4, ENSG00000158711, P28324, Q8IXL1, SAP1
ELKS	ELKS protein	23085	papillary thyroid			RET	23085, A2RU77, CCDS8508.1, Cast2, ELKS, ENSG00000082805, ERC1, KIAA108, KIAA1081, MGC12974, Q8IUD2, RAB6IP2
ELL	ELL gene (11-19 lysine-rich leukemia gene)	8178	AL			MLL	8178, C19orf17, CCDS12380.1, ELL, ELL1, ENSG00000105656, Men, P55199, Q59HG4, Q75MS0
ELN	elastin	2006	B-ALL			PAX5	2006, CCDS5562.2, ELN, ENSG00000049540, FLJ38671, FLJ43523, Q9UMK5, SVAS, WBS, WS
EML4	echinoderm microtubule associated protein like 4	27436	NSCLC			ALK	27436, EML4, ENSG00000143924
EP300	300 kd E1A-Binding protein gene	2033	colorectal, breast, pancreatic, AML, ALL, DLBCL			MLL, RUNXBP2	2033, CCDS14010.1, ENSG00000100393, EP300, RP1-85F18_1, p300
EPS15	epidermal growth factor receptor pathway substrate 15 (AF1p)	2060	ALL			MLL	2060, AF-1P, AF1P, CCDS557.1, ENSG00000085832, EPS15, MLLT5, P42566
ERG	v-ets erythroblastosis virus E26 oncogene like (avian)	2078	Ewing sarcoma, prostate, AML			EWSR1, TMPRSS2, ELF4, FUS, HERPUD1, NDRG1	2078, CCDS13657.1, ERG, P11308
ETV1	ets variant gene 1	2115	Ewing sarcoma, prostate			EWSR1, TMPRSS2, SLC45A3, C15orf21, HNRNPA2B1. ACSL3	2115, DKFZp781L0674, ENSG00000006468, ER81, ETV1, MGC104699, MGC120533, MGC120534
ETV4	ets variant gene 4 (E1A enhancer binding protein, E1AF)	2118	Ewing sarcoma, Prostate carcinoma			EWSR1, TMPRSS2, DDX5, KLK2, CANT1	2118, CCDS11465.1, E1A-F, E1AF, ENSG00000175832, ETV4, PEA3, PEAS3
ETV5	ets variant gene 5	2119	Prostate			TMPRSS2, SCL45A3	2119, CCDS33906.1, ENSG00000244405, ERM, ETV5, P41161, Q6IBN5
ETV6	ets variant gene 6 (TEL oncogene)	2120	congenital fibrosarcoma, multiple leukemia and lymphoma, secretory breast, MDS, ALL			NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5	2120, CCDS8643.1, ENSG00000139083, ETV6, P41212, Q9UME7, TEL, TEL/ABL
EVI1	ecotropic viral integration site 1	2122	AML, CML			RUNX1, ETV6, PRDM16, RPN1	2122, A1L4F3, CCDS3205.1, ENSG00000085276, EVI1, MDS1-EVI1, MECOM, PRDM3, Q03112, Q5HYI1, Q6MZS6, Q8IU84, Q8NEI5
EWSR1	Ewing sarcoma breakpoint region 1 (EWS)	2130	Ewing sarcoma, desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma			FLI1, ERG, ZNF278, NR4A3, FEV, ATF1, ETV1, ETV4, WT1, ZNF384, CREB1, POU5F1, PBX1	2130, CCDS13851.1, ENSG00000182944, EWS, EWSR1
EZR	ezrin	7430	NSCLC			ROS1	7430, CCDS5258.1, CVIL, CVL, DKFZp762H157, ENSG00000092820, EZR, FLJ26216, MGC1584, P15311, Q6NUR7, Q9UJZ2, Q9UJZ6, Q9UJZ7, Q9UJZ8, Q9UK20
FACL6	fatty-acid-coenzyme A ligase, long-chain 6	23305	AML, AEL			ETV6	23305, ACS2, ACSL6, CCDS34228.1, ENSG00000164398, FACL6, KIAA0837, LACS2, LACS5
FAM22A	family with sequence similarity 22, member A	728118	edometrial stromal sarcoma			YWHAE	ENSG00000214562, FAM22A, FAM22D
FAM22B	family with sequence similarity 22, member B	729262	edometrial stromal sarcoma			YWHAE
FCGR2B	Fc fragment of IgG, low affinity IIb, receptor for (CD32)	2213	ALL			?	2213, CCDS30924.1, CD32, CD32B, ENSG00000072694, FCG2, FCGR2, FCGR2B, IGFR2, P31994, Q8IU78, Q8IU79, Q8IXE8, Q8IXE9, Q8IZV7, Q8NI89, Q8NIA0
FEV	FEV protein - (HSRNAFEV)	54738	Ewing sarcoma			EWSR1, FUS	54738, CCDS2428.1, ENSG00000163497, FEV, HSRNAFEV, PET-1, Pet-1
FGFR1	fibroblast growth factor receptor 1	2260	MPD, NHL			BCR, FOP, ZNF198, CEP1	2260, BFGFR, CD331, CEK, ENSG00000077782, FGFBR, FGFR1, FLG, FLT2, H2, H3, H4, H5, HBGFR, KAL2, N-SAM, P11362
FGFR1OP	FGFR1 oncogene partner (FOP)	11116	MPD, NHL			FGFR1	11116, CCDS5297.1, ENSG00000213066, FGFR1OP, FOP
FGFR3	fibroblast growth factor receptor 3	2261	bladder, MM, T-cell lymphoma			IGH@, ETV6	2261, ACH, CCDS3353.1, CD333, CEK2, ENSG00000068078, FGFR3, HSFGFR3EX, JTK4, P22607
FHIT	fragile histidine triad gene	2272	pleomorphic salivary gland adenoma			HMGA2	2272, A2IAS9, A2IAT6, AP3Aase, CCDS2894.1, ENSG00000189283, FHIT, FRA3B, O00298, P49789, Q0MQR8, Q0PUW1, Q194U8, Q194V0, Q1WAB3, Q45QG9, Q5G284, Q71VB2
FIP1L1	FIP1 like 1 (S. cerevisiae)	81608	idiopathic hypereosinophilic syndrome			PDGFRA	81608, CCDS3491.1, DKFZp586K0717, ENSG00000145216, FIP1L1, Q6UN15
FLI1	Friend leukemia virus integration 1	2313	Ewing sarcoma			EWSR1	2313, ENSG00000151702, EWSR2, FLI1, Q01543, SIC-1
FLJ27352	BX648577, FLJ27352 hypothetical LOC145788	145788	PMBL, Hodgkin Lymphona,			CIITA
FNBP1	formin binding protein 1 (FBP17)	23048	AML			MLL	8412, BCAR3, ENSG00000137936, FNBP1, KIAA0554, NSP2, SH2D3B
FOXO1A	forkhead box O1A (FKHR)	2308	alveolar rhabdomyosarcomas			PAX3	2308, CCDS9371.1, ENSG00000150907, FKH1, FKHR, FOXO1, FOXO1A, Q12778
FOXO3A	forkhead box O3A	2309	AL			MLL	2309, AF6q21, CCDS5068.1, DKFZp781A0677, ENSG00000118689, FKHRL1, FKHRL1P2, FOXO2, FOXO3, FOXO3A, MGC12739, MGC31925, O43524, Q68DV3, Q9UPC2
FOXP1	forkhead box P1	27086	ALL			PAX5	12CC4, 27086, CCDS2914.1, ENSG00000114861, FLJ23741, FOXP1, HSPC215, MGC12942, MGC88572, MGC99551, QRF1, hFKH1B
FSTL3	follistatin-like 3 (secreted glycoprotein)	10272	B-CLL			CCND1	10272, CCDS12040.1, ENSG00000070404, FLRG, FSTL3, O95633
FUS	fusion, derived from t(12;16) malignant liposarcoma	2521	liposarcoma, AML, Ewing sarcoma, angiomatoid fibrous histiocytoma, fibromyxoid sarcoma			DDIT3, ERG, FEV, ATF1, CREB3L2, CREB3L1	2521, CCDS10707.1, CHOP, ENSG00000089280, FUS, FUS-CHOP, FUS1, P35637, Q13344, Q6IBQ5, Q8TBR3, TLS, TLS/CHOP
FVT1	follicular lymphoma variant translocation 1	2531	B-NHL			IGK@	2531, CCDS11982.1, ENSG00000119537, FVT1, KDSR, Q06136
GAS7	growth arrest-specific 7	8522	AML*			MLL	8522, CCDS11152.1, ENSG00000007237, GAS7, KIAA0394, MGC1348, MLL/GAS7, O60861, Q29RX5, Q53Y77, Q59GS9, Q7Z571
GMPS	guanine monphosphate synthetase	8833	AML			MLL	8833, ENSG00000163655, GMPS
GOLGA5	golgi autoantigen, golgin subfamily a, 5 (PTC5)	9950	papillary thyroid			RET	9950, CCDS9905.1, ENSG00000066455, GOLGA5, Q2TS49, Q8TBA6, golgin-84, ret-II, rfg5
GPC3	glypican 3	2719		Wilms tumour	Simpson-Golabi-Behmel syndrome		2719, AC002420_1, CCDS14638.1, DGSX, ENSG00000147257, GPC3, OCI-5, P51654, Q1MTS4, Q2L880, Q53H15, Q8IYG2, SDYS, SGB, SGBS, SGBS1
GPHN	gephyrin (GPH)	10243	AL			MLL	10243, CCDS9777.1, ENSG00000171723, GPHN
GRAF	GTPase regulator associated with focal adhesion kinase pp125(FAK)	23092	AML, MDS			MLL	23092, ARHGAP26, ENSG00000145819, FLJ42530, GRAF, KIAA0621, OPHN1L, OPHN1L1
HCMOGT-1	sperm antigen HCMOGT-1	92521	JMML			PDGFRB	92521, CCDS32590.1, CYTSB, ENSG00000128487, FLJ36955, HCMOGT-1, NSP, Q5M775, SPECC1
HEAB	ATP_GTP binding protein	10978	AML			MLL	10978, CCDS7964.1, CLP1, ENSG00000172409, HEAB, Q92989, hClp1
HERPUD1	homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1	9709	prostate			ERG	9709, A4UAE9, CCDS10771.1, ENSG00000051108, HERP, HERPUD1, KIAA0025, Mif1, Q15011, Q53FP9, Q6IAN8, Q9HBR2, SUP
HEY1	hairy/enhancer-of-split related with YRPW motif 1	23462	mesenchymal chondrosarcoma			NCOA2	23462, CCDS6225.1, CHF-2, CHF2, ENSG00000164683, HERP2, HESR-1, HESR1, HEY1, HRT-1, MGC1274, OAF1
HIP1	huntingtin interacting protein 1	3092	CMML			PDGFRB	3092, ENSG00000127946, HIP1, ILWEQ, Q8TDA4
HIST1H4I	histone 1, H4i (H4FM)	8294	NHL			BCL6	8294, CCDS4620.1, HIST1H4I, HIST4H4, MGC24116, P62805, Q0VAS5, Q6B823, Q6DRA9, Q6FGB8, Q6NWP7
HLF	hepatic leukemia factor	3131	ALL			TCF3	3131, CCDS11585.1, ENSG00000108924, HLF, Q16534, Q6FHS9
HLXB9	homeo box HB9	3110	AML			ETV6	3110, CCDS34788.1, ENSG00000130675, HB9, HLXB9, MNX1, P50219, Q9UDY3
HMGA1	high mobility group AT-hook 1	3159	microfollicular thyroid adenoma, various benign mesenchymal tumors,			?	3159, CCDS4789.1, ENSG00000137309, HMG-R, HMGA1, HMGIY, MGC12816, MGC4242, MGC4854, P17096, Q5T6U9
HMGA2	high mobility group AT-hook 2 (HMGIC)	8091	lipoma, leiomyoma, pleiomorphic salivary gland adenoma			LHFP, RAD51L1, LPP, COX6C, CMKOR1, NFIB, ALDH2, CCNB1IP1, EBF1, WIF1, FHIT	8091, BABL, ENSG00000149948, HMGA2, HMGI-C, HMGIC, LIPO
HNRNPA2B1	heterogeneous nuclear ribonucleoprotein A2/B1	3181	prostate			ETV1	3181, CCDS5397.1, ENSG00000122566, HNRNPA2, HNRNPA2B1, HNRNPB1, HNRPA2, HNRPB1, RNPA2, SNRPB1
HOOK3	hook homolog 3	84376	papillary thyroid			RET	84376, CCDS6139.1, ENSG00000168172, HK3, HOOK3, Q86VS8
HOXA11	homeo box A11	3207	CML			NUP98	3207, CCDS5411.1, ENSG00000005073, HOX1, HOX1I, HOXA11, P31270
HOXA13	homeo box A13	3209	AML			NUP98	3209, CCDS5412.1, ENSG00000106031, HOX1, HOX1J, HOXA13, P31271, Q6DI00
HOXA9	homeo box A9	3205	AML*			NUP98, MSI2	3205, CCDS5409.1, ENSG00000078399, HOX1, HOX1G, HOXA9, P31269
HOXC11	homeo box C11	3227	AML			NUP98	3227, CCDS8867.1, ENSG00000123388, HOX3H, HOXC11, O43248
HOXC13	homeo box C13	3229	AML			NUP98	3229, CCDS8865.1, ENSG00000123364, HOX3, HOX3G, HOXC13, P31276, Q6LAM3
HOXD11	homeo box D11	3237	AML			NUP98	3237, CCDS2265.1, ENSG00000128713, HOXD11
HOXD13	homeo box D13	3239	AML*			NUP98	3239, CCDS2264.1, HOX4I, HOXD13, P35453, SPD
HSPCA	heat shock 90kDa protein 1, alpha	3320	NHL			BCL6	3320, CCDS32160.1, ENSG00000080824, FLJ31884, HSP86, HSP90A, HSP90AA1, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2, O75322, P07900, Q14568, Q2VPJ6, Q5CAQ6, Q5CAQ7, Q86SX1, Q86U12, Q8TBA7, Q96HX7
HSPCB	heat shock 90kDa protein 1, beta	3326	NHL			BCL6	3326, CCDS4909.1, D6S182, ENSG00000096384, FLJ26984, HSP90-BETA, HSP90AB1, HSP90B, HSPC2, HSPCB, P08238, Q6PK50, Q9H6X9
IGH@	immunoglobulin heavy locus	3492	MM, Burkitt lymphoma, NHL, CLL, B-ALL, MALT, MLCLS			MYC, FGFR3,PAX5, IRTA1, IRF4, CCND1, BCL9, BCL8, BCL6, BCL2, BCL3, BCL10, BCL11A. LHX4, DDX6, NFKB2, PAFAH1B2, PCSK7, CRLF2
IGK@	immunoglobulin kappa locus	50802	Burkitt lymphoma, B-NHL			MYC, FVT1
IGL@	immunoglobulin lambda locus	3535	Burkitt lymphoma			BCL9, MYC, CCND2
IKZF1	IKAROS family zinc finger 1	10320	ALL, DLBCL			BCL6	10320, ENSG00000185811, Hs_54452, IKAROS, IKZF1, LyF-1, Q13422, ZNFN1A1, hIk-1
IL2	interleukin 2	3558	intestinal T-cell lymphoma			TNFRSF17	3558, CCDS3726.1, ENSG00000109471, IL-2, IL2, P60568, Q0GK43, Q13169, Q16334, Q309Q7, Q6NZ91, Q6NZ93, Q6QWN0, Q71V48, Q7Z7M3, Q8NFA4, Q9C001
IL21R	interleukin 21 receptor	50615	NHL			BCL6	50615, CCDS10630.1, ENSG00000103522, IL21R, Q9HBE5
IRF4	interferon regulatory factor 4	3662	MM			IGH@	3662, CCDS4469.1, ENSG00000137265, IRF4, LSIRF, MUM1, Q15306
IRTA1	immunoglobulin superfamily receptor translocation associated 1	83417	B-NHL			IGH@	83417, CCDS1166.1, ENSG00000163518, FCRH4, FCRL4, IGFP2, IRTA1, Q96PJ5, Q96RE0
ITK	IL2-inducible T-cell kinase	3702	peripheral T-cell lymphoma			SYK	3702, CCDS4336.1, EMT, ENSG00000113263, ITK, LYK, MGC126257, MGC126258, PSCTK2, Q08881
JAK2	Janus kinase 2	3717	ALL, AML, MPD, CML			ETV6, PCM1, BCR	3717, A8K910, A9QVL8, B4DYV1, CCDS6457, ENSG00000096968, JAK2, JAK2_ENST00000381652, JTK10, O60674, Q506Q0, Q52R86, Q8IXP2
JAZF1	juxtaposed with another zinc finger gene 1	221895	endometrial stromal tumours			SUZ12	221895, CCDS5416.1, ENSG00000153814, JAZF1, Q69YN3, Q86VZ6
KDM5A	lysine (K)-specific demethylase 5A, JARID1A	5927	AML			NUP98	5927, ENSG00000073614, JARID1A, KDM5A, RBBP2, RBP2
KIF5B	kinesin family member 5B	3799	NSCLC			RET, ALK	3799, CCDS7171.1, ENSG00000170759, KIF5B, KINH, KNS, KNS1, P33176, Q2TA90, Q66K46, Q6P164, UKHC
KLK2	kallikrein-related peptidase 2	3817	prostate			ETV4	3817, CCDS12808.1, ENSG00000167751, KLK2, KLK2A2, MGC12201, P20151, Q6T775, hK2
KTN1	kinectin 1 (kinesin receptor)	3895	papillary thryoid			RET	3895, CCDS9725.1, CG1, ENSG00000126777, KIAA0004, KTN1, Q17RZ5, Q3SWV9, Q5GGW3, Q6NZ46, Q6PDF7, Q86UP2
LAF4	lymphoid nuclear protein related to AF4	3899	ALL, T-ALL			MLL, RUNX1	3899, AFF3, CCDS33258.1, ENSG00000144218, LAF4, MLLT2-like, P51826
LASP1	LIM and SH3 protein 1	3927	AML			MLL	3927, CCDS11331.1, ENSG00000002834, LASP1, Lasp-1, MLN50, Q14847
LCK	lymphocyte-specific protein tyrosine kinase	3932	T-ALL			TRB@	3932, ENSG00000182866, LCK, P06239, YT16, p56lck, pp58lck
LCP1	lymphocyte cytosolic protein 1 (L-plastin)	3936	NHL			BCL6	3936, CCDS9403.1, CP64, DKFZp781A23186, ENSG00000136167, FLJ25423, FLJ26114, FLJ39956, L-PLASTIN, LC64P, LCP1, P13796, PLS2, Q53FI1, Q59GX5, Q5TBN3, Q5TBN4, Q5TBN5
LCX	leukemia-associated protein with a CXXC domain	80312	AML			MLL	80312, CCDS7281.1, CXXC6, ENSG00000138336, KIAA1676, LCX, Q8NFU7, TET1, bA119F7_1
LHFP	lipoma HMGIC fusion partner	10186	lipoma			HMGA2	10186, CCDS9369.1, ENSG00000183722, LHFP, MGC22429
LIFR	leukemia inhibitory factor receptor	3977	salivary adenoma			PLAG1	3977, CCDS3927.1, CD118, ENSG00000113594, LIFR, SJS2, STWS, SWS
LMO1	LIM domain only 1 (rhombotin 1) (RBTN1)	4004	T-ALL, neuroblastoma	neuroblastoma		TRD@	4004, ENSG00000166407, LMO1, P25800, Q8IXR0, RBTN1, RHOM1, TTG1
LMO2	LIM domain only 2 (rhombotin-like 1) (RBTN2)	4005	T-ALL			TRD@	4005, CCDS7888.1, ENSG00000135363, LMO2, P25791, RBTN2, RBTNL1, RHOM2, TTG2
LPP	LIM domain containing preferred translocation partner in lipoma	4026	lipoma, leukemia			HMGA2, MLL, C12orf9	4026, A1L4L6, CCDS3291.1, ENSG00000145012, LPP, Q93052
LRIG3	leucine-rich repeats and immunoglobulin-like domains 3	121227	NSCLC			ROS1	121227, CCDS8960.1, ENSG00000139263, FLJ26573, FLJ90440, KIAA3016, LRIG3, Q6UXM1
LYL1	lymphoblastic leukemia derived sequence 1	4066	T-ALL			TRB@	4066, CCDS12292.1, ENSG00000104903, LYL1, P12980
MAF	v-maf musculoaponeurotic fibrosarcoma oncogene homolog	4094	MM			IGH@	4094, CCDS10928.1, ENSG00000178573, MAF, MGC71685
MAFB	v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)	9935	MM			IGH@	9935, CCDS13311.1, ENSG00000204103, KRML, MAFB, MGC43127, Q9Y5Q3
MALT1	mucosa associated lymphoid tissue lymphoma translocation gene 1	10892	MALT			BIRC3	10892, CCDS11968.1, ENSG00000172175, MALT1
MAML2	mastermind-like 2 (Drosophila)	84441	salivary gland mucoepidermoid			MECT1, CRTC3	84441, DKFZp686N0150, ENSG00000184384, KIAA1819, MAM-3, MAM2, MAM3, MAML2, MLL-MAML2, Q8IZL2
MDS1	myelodysplasia syndrome 1	4197	MDS, AML			RUNX1	4197, MDS1, MDS1-EVI1, PRDM3, Q13465, Q6FH90
MDS2	myelodysplastic syndrome 2	259283	MDS			ETV6	259283, ENSG00000197880, MDS2, Q8NDY4
MECT1	mucoepidermoid translocated 1	94159	salivary gland mucoepidermoid			MAML2	23373, CCDS32963.1, CRTC1, ENSG00000105662, FLJ14027, KIAA0616, MECT1, Q6UUV9, TORC1, WAMTP1
MKL1	megakaryoblastic leukemia (translocation) 1	57591	acute megakaryocytic leukemia			RBM15	57591, A4FUJ8, BSAC, CCDS14003.1, ENSG00000196588, MAL, MKL1, MRTF-A, Q29R68, Q969V6
MLF1	myeloid leukemia factor 1	4291	AML			NPM1	4291, CCDS3182.1, ENSG00000178053, MLF1, P58340, Q2TLE3, Q2TLE4
MLL	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)	4297	AML, ALL			MLL, MLLT1, MLLT2, MLLT3, MLLT4, MLLT7, MLLT10, MLLT6, ELL, EPS15, AF1Q, CREBBP, SH3GL1, FNBP1, PNUTL1, MSF, GPHN, GMPS, SSH3BP1, ARHGEF12, GAS7, FOXO3A, LAF4, LCX, SEPT6, LPP, CBFA2T1, GRAF, EP300, PICALM, HEAB	4297, ALL-1, CXXC7, ENSG00000118058, HRX, HTRX1, MLL, MLL/GAS7, MLL1A, TRX1
MLLT1	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 (ENL)	4298	AL			MLL	4298, CCDS12160.1, ENL, ENSG00000130382, LTG19, MLLT1, Q03111, YEATS1
MLLT10	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 (AF10)	8028	AL			MLL, PICALM, CDK6	8028, AF10, CCDS7135.1, ENSG00000078403, MLLT10, O60696, P55197, Q59EQ6, Q71UR7
MLLT2	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 2 (AF4)	4299	AL			MLL	4299, AF-4, AFF1, CCDS3616.1, ENSG00000172493, MLLT2, P51825, PBM1, Q05D98, Q14C88, Q6LA76, Q712L1
MLLT3	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 (AF9)	4300	ALL			MLL	4300, AF-9, AF9, CCDS6494.1, ENSG00000171843, MLLT3, P42568, Q5VV08, Q5VV09, Q6LEQ8, Q6MZE2, Q8IVB0, YEATS3
MLLT4	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 (AF6)	4301	AL			MLL	4301, CCDS5303.1, ENSG00000130396, MLLT4, Q5TIG7, Q5TIH1, Q96C95
MLLT6	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 (AF17)	4302	AL			MLL	4302, AF17, CCDS11327.1, ENSG00000108292, MLLT6, P55198, Q59F28, Q96IU3, Q9H5F6
MLLT7	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7 (AFX1)	4303	AL			MLL	4303, AFX1, ENSG00000184481, FOXO4, MLLT7, P98177
MN1	meningioma (disrupted in balanced translocation) 1	4330	AML, meningioma			ETV6	4330, A5HML1, A9Z1V9, CCDS42998.1, ENSG00000169184, MGCR, MGCR1, MGCR1-PEN, MN1, Q10571, dJ353E16_2
MSF	MLL septin-like fusion	10801	AML*			MLL	10801, AF17q25, ENSG00000184640, KIAA0991, MSF, MSF1, NAPB, PNUTL4, SEPT9, SINT1, SeptD1
MSI2	musashi homolog 2 (Drosophila)	124540	CML			HOXA9	124540, CCDS11597.1, ENSG00000153944, MSI2
MSN	moesin	4478	ALCL			ALK	4478, CCDS14382.1, ENSG00000147065, MSN, P26038, Q6PJT4
MTCP1	mature T-cell proliferation 1	4515	T cell prolymphocytic leukemia			TRA@	4515, C6_1B, ENSG00000214827, GS1-273L24_4, MTCP1
MUC1	mucin 1, transmembrane	4582	B-NHL			IGH@	4582, CCDS1098.1, CD227, EMA, ENSG00000185499, H23AG, MAM6, MUC1, PEM, PEMT, PUM, Q14877, Q4VX39, Q7Z545
MYB	v-myb myeloblastosis viral oncogene homolog	4602	adenoid cystic carcinoma			NFIB	4602, CCDS5174.1, Cmyb, ENSG00000118513, MYB, MYB_ENST00000341911, P10242, Q5THS4, Q5THS5, Q708E1, Q708E3, Q708E4, Q708E5, Q708E7, Q708E9, Q708J0, Q9UMI7, c-myb, c-myb_CDS, efg
MYC	v-myc myelocytomatosis viral oncogene homolog (avian)	4609	Burkitt lymphoma, amplified in other cancers, B-CLL			IGK@, BCL5, BCL7A , BTG1, TRA@, IGH@	4609, ENSG00000136997, MYC, c-Myc
MYH11	myosin, heavy polypeptide 11, smooth muscle	4629	AML			CBFB	4629, CCDS10566.1, ENSG00000133392, MYH11, O14729, Q16085, Q3MIV8, Q3MNF0, Q4G140, Q68D89, Q7Z7R0
MYH9	myosin, heavy polypeptide 9, non-muscle	4627	ALCL			ALK	4627, CCDS13927.1, DFNA17, ENSG00000100345, MYH9, P35579, Q2PS10, Q60FE2, Q86XU5, Q99529, Q9UMJ0
MYST4	MYST histone acetyltransferase (monocytic leukemia) 4 (MORF)	23522	AML			CREBBP	23522, CCDS7345.1, DKFZp313G1618, ENSG00000156650, FLJ90335, KIAA0383, MORF, MOZ2, MYST4, Q8WYB5, qkf, querkopf
NACA	nascent-polypeptide-associated complex alpha polypeptide	4666	NHL			BCL6	4666, CCDS31837.1, ENSG00000196531, FKSG17, HSD48, MGC117224, NACA, NACA1, NACAP1, Q13765, Q9BZK3
NCOA1	nuclear receptor coactivator 1	8648	alveolar rhadomyosarcoma			PAX3	8648, CCDS1712.1, ENSG00000084676, F-SRC-1, MGC129719, MGC129720, NCOA1, NCoA-1, RIP160, SRC1
NCOA2	nuclear receptor coactivator 2 (TIF2)	10499	AML, Chondrosarcoma			RUNXBP2, HEY1	10499, ENSG00000140396, GRIP1, MGC138808, NCOA2, NCoA-2, TIF2
NCOA4	nuclear receptor coactivator 4 - PTC3 (ELE1)	8031	papillary thyroid			RET	8031, ARA70, CCDS7237.1, DKFZp762E1112, ELE1, ENSG00000138293, NCOA4, PTC3, Q13772, Q5T1E8, RFG, RP11-481A12_4
NDRG1	N-myc downstream regulated 1	10397	prostate			ERG	10397, CAP43, CCDS34945.1, CMT4D, DRG1, ENSG00000104419, GC4, HMSNL, NDR1, NDRG1, NMSL, PROXY1, Q53EU7, Q597H1, Q6IBG2, Q92597, Q9BRH7, RIT42, RTP, TARG1, TDD5
NFIB	nuclear factor I/B	4781	adenoid cystic carcinoma, lipoma			MYB, HGMA2	4781, CCDS6474.1, ENSG00000147862, NFI-RED, NFIB, NFIB2, NFIB3, NFIB_ENST00000397581, Q5VW26, RP11-280O24_2
NFKB2	nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)	4791	B-NHL			IGH@	4791, A8K9D9, CCDS41565.1, ENSG00000077150, LYT-10, LYT10, NFKB2
NIN	ninein (GSK3B interacting protein)	51199	MPD			PDGFRB	51199, CCDS32078.1, ENSG00000100503, KIAA1565, NIN
NONO	non-POU domain containing, octamer-binding	4841	papillary renal cancer			TFE3	4841, CCDS14410.1, ENSG00000147140, NMT55, NONO, NRB54, P54, P54NRB, Q15233
NOTCH1	Notch homolog 1, translocation-associated (Drosophila) (TAN1)	4851	T-ALL			TRB@	4851, ENSG00000148400, NOTCH1, P46531, Q59ED8, Q5SXM3, TAN1, hN1
NPM1	nucleophosmin (nucleolar phosphoprotein B23, numatrin)	4869	NHL, APL, AML			ALK, RARA, MLF1	4869, B23, CCDS4376.1, ENSG00000181163, MGC104254, NPM, NPM1, P06748
NR4A3	nuclear receptor subfamily 4, group A, member 3 (NOR1)	8013	extraskeletal myxoid chondrosarcoma			EWSR1	8013, A2A3I7, CCDS6742.1, CHN, CSMF, ENSG00000119508, MINOR, NOR1, NR4A3, Q92570, TEC
NSD1	nuclear receptor binding SET domain protein 1	64324	AML			NUP98	64324, ARA267, CCDS4412.1, DKFZp666C163, ENSG00000165671, FLJ22263, FLJ44628, NSD1, Q658U6, Q8NB95, Q96DQ7, Q96L73, Q96MN8, Q9H6B5, Q9H6H8, SOTOS, STO
NTRK1	neurotrophic tyrosine kinase, receptor, type 1	4914	papillary thyroid			TPM3, TPR, TFG	4914, CCDS1161.1, DKFZp781I14186, ENSG00000198400, MTC, NTRK1, P04629, TRK, TRK1, TRKA, p140-TrkA
NTRK3	neurotrophic tyrosine kinase, receptor, type 3	4916	congenital fibrosarcoma, Secretory breast			ETV6	4916, CCDS10340.1, ENSG00000140538, NTRK3, Q16288, TRKC, gp145(trkC)
NUMA1	nuclear mitotic apparatus protein 1	4926	APL			RARA	4926, CCDS31633.1, ENSG00000137497, NUMA, NUMA1, Q14980, Q3SYK8, Q4LE64, Q86XH4, Q9UNL7, Q9UPG3
NUP214	nucleoporin 214kDa (CAN)	8021	AML, T-ALL			DEK, SET, ABL1	8021, CAIN, CAN, CCDS6940.1, D9S46E, ENSG00000126883, MGC104525, N214, NUP214, P35658, Q3KQZ0, Q5JUP7, Q5JUP9, Q75R47, Q7Z3C4, Q86XD3, RP11-544A12_7
NUP98	nucleoporin 98kDa	4928	AML			HOXA9, NSD1, WHSC1L1, DDX10, TOP1, HOXD13, PMX1, HOXA13, HOXD11, HOXA11, RAP1GDS1, HOXC11	4928, ADIR2, CCDS7746.1, ENSG00000110713, NUP196, NUP98
OLIG2	oligodendrocyte lineage transcription factor 2 (BHLHB1)	10215	T-ALL			TRA@	10215, BHLHB1, CCDS13620.1, ENSG00000205927, OLIG2, OLIGO2, PRKCBP2, RACK17
OMD	osteomodulin	4958	aneurysmal bone cysts			USP6	4958, CCDS6696.1, ENSG00000127083, OMD, Q5TBF4, Q99983, SLRR2C, osteoadherin
P2RY8	purinergic receptor P2Y, G-protein coupled, 8	286530	B-ALL, Downs associated ALL			CRLF2	286530, CCDS14115.1, ENSG00000182162, MGC50878, P2RY8, P2Y8, Q86VZ1, RP11-261P4_4
PAFAH1B2	platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 30kDa	5049	MLCLS			IGH@	5049, CCDS8380.1, ENSG00000168092, P68402, PAFAH1B2, Q6IBR6
PAX3	paired box gene 3	5077	alveolar rhabdomyosarcoma			FOXO1A, NCOA1	5077, CCDS2448.1, CDHS, ENSG00000135903, HUP2, MGC120381, MGC120382, MGC120383, MGC120384, MGC134778, P23760, PAX3, Q12777, Q494Z3, Q494Z4, WS1
PAX5	paired box gene 5 (B-cell lineage specific activator protein)	5079	NHL, ALL, B-ALL			IGH@, ETV6, PML, FOXP1, ZNF521, ELN	5079, BSAP, CCDS6607.1, ENSG00000196092, PAX5, Q02548, Q5VVI9
PAX7	paired box gene 7	5081	alveolar rhabdomyosarcoma			FOXO1A	5081, CCDS186.1, ENSG00000009709, HUP1, P23759, PAX7, PAX7B, Q0VA99, Q2PJS5
PAX8	paired box gene 8	7849	follicular thyroid			PPARG	7849, ENSG00000125618, PAX8
PBX1	pre-B-cell leukemia transcription factor 1	5087	pre B-ALL, myoepithelioma			TCF3, EWSR1	5087, CCDS1246.1, P40424, PBX1, Q5T487, Q68DD6
PCM1	pericentriolar material 1 (PTC4)	5108	papillary thyroid, CML, MPD			RET, JAK2	5108, B4DWY1, B4DYD5, ENSG00000078674, PCM1, PTC4, Q15154
PCSK7	proprotein convertase subtilisin/kexin type 7	9159	MLCLS			IGH@	9159, CCDS8382.1, ENSG00000160613, LPC, PC7, PC8, PCSK7, Q16549, Q3C1X1, Q53GM4, Q6PK65, Q96FK8, SPC7
PDE4DIP	phosphodiesterase 4D interacting protein (myomegalin)	9659	MPD			PDGFRB	9659, CCDS30824.1, ENSG00000178104, PDE4DIP, Q5VU42, Q5VU43, Q5VU47, Q68DU2, Q86T40, Q8N3W0, Q9HCP3, Q9HCP4, Q9HCP5
PDGFB	platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog)	5155	DFSP			COL1A1	5155, A2NWD3, CCDS13987.1, ENSG00000100311, FLJ12858, P01127, P78450, PDGF2, PDGFB, Q6FHE7, Q9UE56, Q9UE57, SIS, SSV, c-sis
PDGFRA	platelet-derived growth factor, alpha-receptor	5156	GIST, idiopathic hypereosinophilic syndrome, paediatric GBM			FIP1L1	5156, CCDS3495.1, CD140A, CD140a, ENSG00000134853, MGC74795, P16234, PDGFR2, PDGFRA, Rhe-PDGFRA
PDGFRB	platelet-derived growth factor receptor, beta polypeptide	5159	MPD, AML, CMML, CML			ETV6, TRIP11, HIP1, RAB5EP, H4, NIN, HCMOGT-1, PDE4DIP	5159, CCDS4303.1, CD140B, CD140b, ENSG00000113721, JTK12, P09619, PDGF-R-beta, PDGFR, PDGFR1, PDGFRB
PER1	period homolog 1 (Drosophila)	5187	AML, CMML			ETV6	5187, A2I2P6, CCDS11131.1, ENSG00000179094, O15534, PER, PER1, Q6IN51, Q8N6U1, Q9H2D0, RIGUI
PICALM	phosphatidylinositol binding clathrin assembly protein (CALM)	8301	TALL, AML,			MLLT10, MLL	8301, CALM, CCDS8272.1, CLTH, ENSG00000073921, PICALM, Q13492, Q4LE54
PIM1	pim-1 oncogene	5292	NHL			BCL6	5292, ENSG00000137193, P11309, PIM, PIM1
PLAG1	pleiomorphic adenoma gene 1	5324	salivary adenoma			TCEA1, LIFR, CTNNB1, CHCHD7	5324, CCDS6165.1, ENSG00000181690, PLAG1, Q59GH8, Q6DJT9, Q9Y4L2
PML	promyelocytic leukemia	5371	APL, ALL			RARA, PAX5	5371, CCDS10255.1, ENSG00000140464, MYL, PML, PP8675, RNF71, TRIM19
PMX1	paired mesoderm homeo box 1	5396	AML			NUP98	5396, CCDS1291.1, ENSG00000116132, PMX1, PRRX1
PNUTL1	peanut-like 1 (Drosophila)	5413	AML			MLL	5413, CCDS13764.1, ENSG00000184702, H5, HCDCREL-1, O95648, PNUTL1, Q99719, SEPT5
POU2AF1	POU domain, class 2, associating factor 1 (OBF1)	5450	NHL			BCL6	5450, BOB1, CCDS31675.1, ENSG00000110777, OBF-1, OBF1, OCAB, POU2AF1, Q16633
POU5F1	POU domain, class 5, transcription factor 1	5460	sarcoma			EWSR1	5460, ENSG00000230336, MGC22487, OCT3, OCT4, OTF3, OTF3C, OTF3P1, OTF4, Oct4, POU5F1, POU5F1P1
PPARG	peroxisome proliferative activated receptor, gamma	5468	follicular thyroid			PAX8	5468, CCDS2609.1, ENSG00000132170, HUMPPARG, NR1C3, PPARG, PPARG1, PPARG2
PRCC	papillary renal cell carcinoma (translocation-associated)	5546	papillary renal			TFE3	5546, CCDS1157, CCDS1158.1, ENSG00000143294, MGC17178, MGC4723, PRCC, PRCC_ENST00000353233, Q5SZ06, Q92733, Q96FT4, RCCP1, TPRC
PRDM16	PR domain containing 16	63976	MDS, AML			EVI1	63976, ENSG00000142611, KIAA1675, MEL1, PFM13, PRDM16, Q5VU54, Q9HAZ2
PRKAR1A	protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)	5573	papillary thyroid	myxoma, endocrine, papillary thyroid	Carney complex	RET	5573, CAR, CCDS11678.1, CNC, CNC1, DKFZp779L0468, ENSG00000108946, MGC17251, P10644, PKR1, PPNAD1, PRKAR1, PRKAR1A, Q68DQ4, Q96P62, TSE1
PRO1073	PRO1073 protein (ALPHA)	29005	renal cell carcinoma (childhood epithelioid)			TFEB	29005, PRO1073, Q9UHZ2
PSIP2	PC4 and SFRS1 interacting protein 2 (LEDGF)	11168	AML			NUP98	11168, CCDS6480.1, ENSG00000164985, PSIP1, PSIP2, Q05CM9, Q8N4N4
RAB5EP	rabaptin, RAB GTPase binding effector protein 1 (RABPT5)	9135	CMML			PDGFRB	9135, ENSG00000029725, Q05BX6, Q15276, RAB5EP, RABEP1, RABPT5, neurocrescin, rabaptin-5
RAD51L1	RAD51-like 1 (S. cerevisiae) (RAD51B)	5890	lipoma, uterine leiomyoma			HMGA2	5890, CCDS9789.1, ENSG00000182185, MGC34245, O15315, R51H2, RAD51B, RAD51L1, REC2, hREC2
RAF1	v-raf-1 murine leukemia viral oncogene homolog 1	5894	pilocytic astrocytoma			SRGAP3	5894, CCDS2612.1, CRAF, ENSG00000132155, P04049, RAF1, Raf-1, c-Raf
RALGDS	ral guanine nucleotide dissociation stimulator	5900	PMBL, Hodgkin Lymphona,			CIITA	5900, CCDS6959.1, ENSG00000160271, FLJ20922, Q12967, Q5T7V4, Q6ZSD5, Q8N4Y1, Q8NF31, Q8WU11, Q9HAX8, Q9HAX9, Q9HAY0, RALGDS, RGF, RalGEF
RANBP17	RAN binding protein 17	64901	ALL			TRD@	64901, CCDS34287.1, ENSG00000204764, FLJ32916, Q546R4, Q8IU74, Q8IVM9, Q96M10, Q9H2T7, RANBP17
RAP1GDS1	RAP1, GTP-GDP dissociation stimulator 1	5910	T-ALL			NUP98	5910, ENSG00000138698, GDS1, MGC118859, MGC118861, P52306, Q4QQI8, Q9BUX6, RAP1GDS1
RARA	retinoic acid receptor, alpha	5914	APL			PML, ZNF145, TIF1, NUMA1, NPM1	5914, CCDS11366.1, ENSG00000131759, NR1B1, RAR, RARA
RBM15	RNA binding motif protein 15	64783	acute megakaryocytic leukemia			MKL1	64783, A1A693, CCDS822.1, ENSG00000162775, OTT, OTT1, Q59EY1, Q96T37, RBM15
RET	ret proto-oncogene	5979	medullary thyroid, papillary thyroid, pheochromocytoma, NSCLC	medullary thyroid, papillary thyroid, pheochromocytoma	Multiple endocrine neoplasia 2A/2B	H4, PRKAR1A, NCOA4, PCM1, GOLGA5, TRIM33, KTN1, TRIM27, HOOK3, KIF5B, CCDC6	5979, CCDS7200.1, CDHF12, ENSG00000165731, HSCR1, MEN2A, MEN2B, MTC1, P07949, PTC, RET, RET-ELE1, RET51
ROS1	v-ros UR2 sarcoma virus oncogene homolog 1 (avian)	6098	glioblastoma, NSCLC			GOPC, SDC4, SLC34A2, EZR, LRIG3	6098, ENSG00000047936, MCF3, P08922, ROS, ROS1, RP1-179P9_1
RPL22	ribosomal protein L22 (EAP)	6146	AML, CML			RUNX1	6146, CCDS58.1, EAP, RPL22
RPN1	ribophorin I	6184	AML			EVI1	6184, CCDS3051.1, ENSG00000163902, OST1, P04843, Q53EP4, Q68DT1, Q6IBR0, Q96HX3, RPN1
RUNDC2A	RUN domain containing 2A	84127	PMBL, Hodgkin Lymphona,			CIITA	84127, CCDS10553.1, ENSG00000140660, FLJ12363, Q9HA26, RUNDC2A
RUNX1	runt-related transcription factor 1 (AML1)	861	AML, preB- ALL, T-ALL			RPL22, MDS1, EVI1, CBFA2T3, CBFA2T1, ETV6, LAF4	861, AML1, AMLCR1, CBFA2, CCDS13639.1, ENSG00000159216, PEBP2A2, Q01196, RUNX1
RUNXBP2	runt-related transcription factor binding protein 2 (MOZ/ZNF220)	7994	AML			CREBBP, NCOA2, EP300	7994, CCDS6124.1, ENSG00000083168, MOZ, MYST3, Q92794, RUNXBP2, ZNF220
SDC4	syndecan 4	6385	NSCLC			ROS1	6385, CCDS13350.1, ENSG00000124145, MGC22217, P31431, Q53FN9, Q6FGN3, SDC4, SYND4
SEPT6	septin 6	23157	AML			MLL	23157, CCDS14584.1, ENSG00000125354, KIAA0128, MGC16619, MGC20339, Q14141, Q5JTK3, Q6B514, Q6NT82, Q8NFH9, RP5-876A24_2, SEP2, SEPT2, SEPT6
SET	SET translocation	6418	AML			NUP214	2PP2A, 6418, CCDS6907.1, ENSG00000119335, ENSG00000181555, I2PP2A, IGAAD, PHAPII, SET, SETD2, SETD2_ENST00000409792, TAF-IBETA
SFPQ	splicing factor proline/glutamine rich(polypyrimidine tract binding protein associated)	6421	papillary renal cell			TFE3	6421, CCDS388.1, ENSG00000116560, P23246, PSF, Q5SZ71, Q6PIX2, Q86VG2, Q9BSV4, SFPQ
SFRS3	splicing factor, arginine/serine-rich 3	6428	follicular lymphoma			BCL6	6428, CCDS4823.1, ENSG00000112081, P84103, Q5R3K0, SFRS3, SRSF3, SRp20
SH3GL1	SH3-domain GRB2-like 1 (EEN)	6455	AL			MLL	6455, CCDS32874.1, CNSA1, EEN, ENSG00000141985, Q6FGM0, Q99961, Q9BVL7, Q9BWP4, Q9UQD4, SH3D2B, SH3GL1, SH3P8
SIL	TAL1 (SCL) interrupting locus	6491	T-ALL			TAL1	6491, CCDS548.1, ENSG00000123473, Q15468, Q5T0C6, Q5T0C9, Q5T0D0, SIL, STIL
SLC34A2	solute carrier family 34 (sodium phosphate), member 2	10568	NSCLC			ROS1	10568, CCDS3435.1, ENSG00000157765, FLJ90534, NAPI-3B, NAPI-IIb, NPTIIb, O95436, SLC34A2
SLC45A3	solute carrier family 45, member 3	85414	prostate			ETV1, ETV5, ELK4, ERG	85414, CCDS1458.1, ENSG00000158715, IPCA-6, IPCA6, PCANAP6, PRST, Q658X7, Q96JT2, SLC45A3
SRGAP3	SLIT-ROBO Rho GTPase activating protein 3	9901	pilocytic astrocytoma			RAF1	9901, ARHGAP14, CCDS2572.1, ENSG00000196220, KIAA0411, MEGAP, SRGAP2, SRGAP3, WRP
SS18	synovial sarcoma translocation, chromosome 18	6760	synovial sarcoma			SSX1, SSX2	6760, CCDS32807.1, ENSG00000141380, Q15532, Q4VAX2, Q8TDQ9, SS18, SSXT, SYT
SS18L1	synovial sarcoma translocation gene on chromosome 18-like 1	26039	synovial sarcoma			SSX1	26039, CCDS13491.1, ENSG00000184402, KIAA0693, O75177, Q6MZV9, Q6XYD9, SS18L1
SSH3BP1	spectrin SH3 domain binding protein 1	10006	AML			MLL	10006, ABI-1, ABI1, CCDS7150.1, E3B1, SSH3BP1
SSX1	synovial sarcoma, X breakpoint 1	6756	synovial sarcoma			SS18	6756, CCDS14290.1, ENSG00000126752, MGC150425, MGC5162, Q16384, RP11-552E4_1, SSRC, SSX1
SSX2	synovial sarcoma, X breakpoint 2	6757	synovial sarcoma			SS18	6757, CCDS14345.1, ENSG00000157950, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, Q8WWZ9, Q9NZK4, RP11-552J9_2, SSX, SSX2
SSX4	synovial sarcoma, X breakpoint 4	6759	synovial sarcoma			SS18	6759, CCDS35240.1, ENSG00000204645, MGC119056, MGC12411, O60224, SSX4
STL	Six-twelve leukemia gene	7955	B-ALL			ETV6
SUZ12	suppressor of zeste 12 homolog (Drosophila)	23512	endometrial stromal tumours			JAZF1	23512, CCDS11270.1, CHET9, ENSG00000178691, JJAZ1, KIAA0160, Q15022, SUZ12
SYK	spleen tyrosine kinase	6850	MDS, peripheral T-cell lymphoma			ETV6, ITK	6850, CCDS6688.1, ENSG00000165025, P43405, SYK
TAF15	TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa	8148	extraskeletal myxoid chondrosarcomas, ALL			TEC, CHN1, ZNF384	8148, CCDS32623.1, ENSG00000172660, Npl3, Q86X94, Q92804, RBP56, TAF15, TAF2N, hTAFII68
TAL1	T-cell acute lymphocytic leukemia 1 (SCL)	6886	lymphoblastic leukemia/biphasic			TRD@, SIL	6886, CCDS547.1, ENSG00000162367, P17542, Q16509, Q9UE36, SCL, TAL1, TCL5, tal-1
TAL2	T-cell acute lymphocytic leukemia 2	6887	T-ALL			TRB@	6887, CCDS6767.1, Q16559, TAL2
TCEA1	transcription elongation factor A (SII), 1	6917	salivary adenoma			PLAG1	6917, ENSG00000187735, TCEA1
TCF12	transcription factor 12 (HTF4, helix-loop-helix transcription factors 4)	6938	extraskeletal myxoid chondrosarcoma			TEC	6938, CCDS10160.1, ENSG00000140262, HEB, HTF4, HsT17266, Q86VM2, Q9NQY1, Q9NQY2, Q9NQY3, Q9NQY4, Q9NQY5, Q9NQY6, Q9NQY7, Q9NQY9, TCF12
TCF3	transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	6929	pre B-ALL			PBX1, HLF, TFPT	6929, CCDS12074.1, E2A, ENSG00000071564, ITF1, MGC129647, MGC129648, P15923, Q6PJU3, TCF3
TCF7L2	transcription factor 7-like 2	6934	colorectal			VTI1A	6934, CCDS7576.1, ENSG00000148737, Q6FHW4, TCF-4, TCF4, TCF7L2
TCL1A	T-cell leukemia/lymphoma 1A	8115	T-CLL			TRA@	8115, CCDS9941.1, ENSG00000100721, P56279, TCL1, TCL1A
TCL6	T-cell leukemia/lymphoma 6	27004	T-ALL			TRA@	27004, CCDS9940.1, ENSG00000187621, P56847, Q9NPH1, TCL6
TFE3	transcription factor binding to IGHM enhancer 3	7030	papillary renal, alveolar soft part sarcoma, renal			SFPQ, ASPSCR1, PRCC, NONO, CLTC	7030, CCDS14315.2, ENSG00000068323, RCCP2, TFE3, TFEA
TFEB	transcription factor EB	7942	renal (childhood epithelioid)			ALPHA	7942, AlphaTFEB, CCDS4858.1, ENSG00000112561, P19484, Q4VXW8, Q4VXX0, Q5QPI1, Q5QPI2, Q709A5, Q709A8, Q709A9, Q86WB1, TCFEB, TFEB
TFG	TRK-fused gene	10342	papillary thyroid, ALCL, NSCLC			NTRK1, ALK	10342, CCDS2939.1, ENSG00000114354, Q7Z426, Q7Z427, Q92734, Q969I2, TF6, TFG
TFPT	TCF3 (E2A) fusion partner (in childhood Leukemia)	29844	pre-B ALL			TCF3	29844, CCDS12878.1, ENSG00000105619, P0C1Z6, TFPT
TFRC	transferrin receptor (p90, CD71)	7037	NHL			BCL6	7037, CCDS3312.1, CD71, ENSG00000072274, P02786, Q1HE24, TFR1, TFRC
THRAP3	thyroid hormone receptor associated protein 3 (TRAP150)	9967	aneurysmal bone cysts			USP6	9967, CCDS405.1, ENSG00000054118, FLJ22082, MGC133082, MGC133083, Q05D20, Q6P0P7, Q6PJV4, Q7Z5U1, Q9Y2W1, THRAP3, TRAP150
TIF1	transcriptional intermediary factor 1 (PTC6,TIF1A)	8805	APL			RARA	8805, CCDS5847.1, ENSG00000122779, P04720, PTC6, RNF82, TF1A, TIF1, TIF1A, TIF1ALPHA, TRIM24, Tif1a, hTIF1
TLX1	T-cell leukemia, homeobox 1 (HOX11)	3195	T-ALL			TRB@, TRD@	3195, A1L4G3, CCDS7510.1, ENSG00000107807, HOX11, P31314, Q5VXP2, Q9UD59, TCL3, TLX1
TLX3	T-cell leukemia, homeobox 3 (HOX11L2)	30012	T-ALL			BCL11B	30012, CCDS34288.1, ENSG00000164438, HOX11L2, O43711, RNX, TLX3
TMPRSS2	transmembrane protease, serine 2	7113	prostate			ERG, ETV1, ETV4, ETV5	7113, CCDS33564.1, ENSG00000184012, O15393, PRSS10, Q96T73, TMPRSS2
TNFRSF17	tumor necrosis factor receptor superfamily, member 17	608	intestinal T-cell lymphoma			IL2	608, BCM, BCMA, CCDS10552.1, CD269, ENSG00000048462, Q02223, Q6PE46, TNFRSF17
TOP1	topoisomerase (DNA) I	7150	AML*			NUP98	7150, CCDS13312.1, ENSG00000198900, P11387, Q6NWZ5, Q6PK95, Q9BVT2, RP3-511B24_2, TOP1, TOPI
TPM3	tropomyosin 3	7170	papillary thyroid, ALCL, NSCLC			NTRK1, ALK, ROS1	7170, CCDS1060.1, ENSG00000143549, TPM3
TPM4	tropomyosin 4	7171	ALCL			ALK	7171, CCDS12338.1, ENSG00000167460, P67936, Q5U0D9, TPM4
TPR	translocated promoter region	7175	papillary thyroid			NTRK1	7175, A0PJC9, P12270, TPR
TRA@	T cell receptor alpha locus	6955	T-ALL			ATL,OLIG2, MYC, TCL1A, TCL6, MTCP1, TCL6
TRB@	T cell receptor beta locus	6957	T-ALL			HOX11, LCK, NOTCH1, TAL2, LYL1
TRD@	T cell receptor delta locus	6964	T-cell leukemia			TAL1, HOX11, TLX1, LMO1, LMO2, RANBP17
TRIM27	tripartite motif-containing 27	5987	papillary thyroid			RET	5987, CCDS4654.1, DASS-46L4_6, ENSG00000234495, RFP, RNF76, TRIM27
TRIM33	tripartite motif-containing 33 (PTC7,TIF1G)	51592	papillary thyroid			RET	51592, ENSG00000197323, FLJ32925, PTC7, Q9UPN9, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA, TRIM33
TRIP11	thyroid hormone receptor interactor 11	9321	AML			PDGFRB	9321, CCDS9899.1, CEV14, ENSG00000100815, Q15643, Q6MZL5, TRIP11, Trip230
TTL	tubulin tyrosine ligase	150465	ALL			ETV6	150465, 2410003M22Rik, 284076, CCDS2096.1, ENSG00000114999, ENSG00000170703, FLJ35808, MGC46235, Q585T3, Q8N841, Q8NG68, TTL, TTLL6_ENST00000393382, TTL_6
USP6	ubiquitin specific peptidase 6 (Tre-2 oncogene)	9098	aneurysmal bone cysts			COL1A1, CDH11, ZNF9, OMD	9098, ENSG00000129204, HRP1, TRE17, TRE2, Tre-2, USP6
VTI1A	vesicle transport through interaction with t-SNAREs homolog 1A	143187	colorectal			TCF7L2	143187, CCDS7575.2, ENSG00000151532, MVti1, Q5W0D7, VTI1A, Vti1-rp2
WHSC1	Wolf-Hirschhorn syndrome candidate 1(MMSET)	7468	MM			IGH@	7468, B3VCH6, CCDS33940, D3DVQ2, FLJ23286, KIAA1090, MGC176638, MMSET, NSD2, O96028, REIIBP, TRX5, WHS, WHSC1, WHSC1_ENST00000382891
WHSC1L1	Wolf-Hirschhorn syndrome candidate 1-like 1 (NSD3)	54904	AML			NUP98	54904, CCDS6105.1, ENSG00000147548, WHSC1L1
WIF1	WNT inhibitory factor 1	11197	pleomorphic salivary gland adenoma			HMGA2	11197, CCDS8971.1, ENSG00000156076, WIF-1, WIF1
WWTR1	WW domain containing transcription regulator 1	607392	epitheliod hemangioendothelioma			CAMTA1	25937, CCDS3144.1, DKFZP586I1419, ENSG00000018408, Q9GZV5, TAZ, WWTR1
YWHAE	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide (14-3-3 epsilon)	7531	edometrial stromal sarcoma			FAM22a, FAM22B	14-3-3 epsilon, 14-3-3E, 7531, CCDS11001.1, ENSG00000108953, FLJ45465, KCIP-1, MDCR, MDS, P62258, Q4VJB6, Q53XZ5, YWHAE
ZNF145	zinc finger protein 145 (PLZF)	7704	APL			RARA	7704, CCDS8367.1, ENSG00000109906, PLZF, Q05516, Q59H43, Q71UL5, Q71UL6, Q71UL7, ZBTB16, ZNF145
ZNF198	zinc finger protein 198	7750	MPD, NHL			FGFR1	7750, ENSG00000121741, FIM, MYM, Q5W0Q3, Q9UBW7, RAMP, ZMYM2, ZNF198
ZNF278	zinc finger protein 278 (ZSG)	23598	Ewing sarcoma			EWSR1	23598, CCDS13896.1, ENSG00000100105, PATZ1, Q9HD72, ZNF278
ZNF331	zinc finger protein 331	55422	follicular thyroid adenoma			?	55422, CCDS33102.1, ENSG00000130844, Q68D63, Q6PK05, Q71QC3, Q71QC4, Q71QC5, Q71QC6, Q71QC8, Q71QC9, Q8NBU2, Q9NQX6, RITA, ZNF331, ZNF361, ZNF463
ZNF384	zinc finger protein 384 (CIZ/NMP4)	171017	ALL			EWSR1, TAF15	171017, CCDS8557.1, ENSG00000126746, ZNF384
ZNF521	zinc finger protein 521	25925	ALL			PAX5	25925, CCDS32806.1, DKFZp564D0764, EHZF, ENSG00000198795, Evi3, MGC142182, MGC142208, Q8IXI0, Q8IYZ2, Q8TES6, Q96K83, Q9C065, Q9HAL5, Q9UFK4, ZNF521
ZNF9	zinc finger protein 9 (a cellular retroviral nucleic acid binding protein)	7555	aneurysmal bone cysts			USP6	7555, CCDS3056.1, CNBP, DM2, ENSG00000169714, P62633, Q4JGY0, Q4JGY1, Q5U0E9, Q6T598, RNF163, ZNF9

A, amplification; AEL, acute eosinophilic leukemia; AL, acute leukemia; ALCL, anaplastic large-cell lymphoma; ALL, acute lymphocytic leukemia; AML, acute myelogenous leukemia; AML*, acute myelogenous leukemia (primarily treatment associated); APL, acute promyelocytic leukemia; B-ALL, B-cell acute lymphocytic leukaemia; B-CLL, B-cell Lymphocytic leukemia; B-NHL, B-cell Non-Hodgkin Lymphoma; CLL, chronic lymphatic leukemia; CML, chronic myeloid leukemia; CMML, chronic myelomonocytic leukemia; CNS, central nervous system; D, large deletion; DFSP, dermatofibrosarcoma protuberans; DLBL, diffuse large B-cell lymphoma; DLCL, diffuse large-cell lymphoma; Dom, dominant; E, epithelial; F, frameshift; GIST, gastrointestinal stromal tumour; JMML, juvenile myelomonocytic leukemia; L, leukaemia/lymphoma; M, mesenchymal; MALT, mucosa-associated lymphoid tissue lymphoma; MDS, myelodysplastic syndrome; Mis, Missense; MLCLS, mediastinal large cell lymphoma with sclerosis; MM, multiple myeloma; MPD, Myeloproliferative disorder; N, nonsense; NHL, non-Hodgkin lymphoma; NK/T, natural killer T cell; NSCLC, non small cell lung cancer; O, other; PMBL, primary mediastinal B-cell lymphoma; pre-B All, pre-B-cell acute lymphoblastic leukaemia; Rec, recesive; S, splice site; T, translocation; T-ALL, T-cell acute lymphoblastic leukemia; T-CLL, T-cell chronic lymphocytic leukaemia; TGCT, testicular germ cell tumour; T-PLL, T cell prolymphocytic leukaemia;